Vijaya Diagnostic Centre Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Vijaya Diagnostic share price target 2026 stands at Rs 987-1,140 as per analyst consensus — implying 20-39% upside from the current CMP of Rs 820. Investors tracking the Vijaya Diagnostic share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Vijaya Diagnostic Centre (VIJAYA) achieves or misses this 12-month target. This article covers every dimension of the Vijaya Diagnostic share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Vijaya Diagnostic Centre on Univest.

Table of Contents

Vijaya Diagnostic Centre Share Price Overview — April 2026

Company	Vijaya Diagnostic Centre
NSE Symbol	VIJAYA
Sector	Diagnostics / South India / Pathology / Radiology
CMP April 2026	Rs 820
52-Week High	Rs 1,120
52-Week Low	Rs 650
Market Cap	Rs 9,600 Cr
Trailing P/E	42x
Dividend FY26	Rs 5
Promoter Holding	71.7%
FII Holding	14.8%
12M Analyst Target	Rs 987-1,140
Upside from CMP	20-39%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Vijaya Diagnostic Centre price, FII/DII flows and analyst targets on the Univest Screener.

What Is Vijaya Diagnostic Centre?

Get Free Analyst Research on Vijaya Diagnostic Centre — Tap Here.

Vijaya Diagnostic Centre (NSE: VIJAYA) is South India’s leading diagnostics chain — 150+ centres in Hyderabad, Vizag, Tier 2 AP/Telangana. Premium radiology (MRI, CT, PET-CT) drives 40%+ of revenue. Corporate wellness growing 25%+ annually.

Budget 2026-27 Impact on Diagnostics

Budget 2026-27’s preventive healthcare and corporate wellness push in South India’s growing IT workforce expands Vijaya’s premium diagnostics market.

Vijaya Diagnostic share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 987	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 987-1,140	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 650 zone	FY27 miss and extended FII selling

Compare Vijaya Diagnostic Centre with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Vijaya Diagnostic share price target 2026

1. India Diagnostics Sector — Structural Growth Tailwind

India’s Diagnostics sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Vijaya Diagnostic Centre’s market position within this sector creates compounding runway that underpins the Vijaya Diagnostic share price target 2026 consensus of Rs 987-1,140. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Vijaya Diagnostic Centre to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Vijaya Diagnostic share price target 2026 consensus of Rs 987-1,140. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Vijaya Diagnostic Centre holds a structural competitive moat in its Diagnostics segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Vijaya Diagnostic share price target 2026 of Rs 987-1,140.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Vijaya Diagnostic Centre’s borrowing costs and stimulates end-customer demand for Diagnostics products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Vijaya Diagnostic share price target 2026 of Rs 987-1,140 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Vijaya Diagnostic Centre’s Diagnostics business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Vijaya Diagnostic share price target 2026 bull case.

Download the Univest iOS App or Android App for live Vijaya Diagnostic Centre alerts and SEBI-registered research.

5 Risks That Could Impact the Vijaya Diagnostic share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Vijaya Diagnostic Centre. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Vijaya Diagnostic share price target 2026 consensus of Rs 987-1,140.

2. Valuation at 42x Requires Consistent Execution

At 42x trailing P/E, Vijaya Diagnostic Centre is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Vijaya Diagnostic share price target 2026. The Rs 650 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in Diagnostics

Domestic and global competitors are investing aggressively in Vijaya Diagnostic Centre’s Diagnostics market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Vijaya Diagnostic share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Vijaya Diagnostic share price target 2026 of Rs 987-1,140.

5. FII Selling Risk — 14.8% Institutional Holding

With 14.8% FII ownership, Vijaya Diagnostic Centre is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Vijaya Diagnostic share price target 2026 analyst consensus of Rs 987-1,140.

Vijaya Diagnostic Centre Bull Case vs Bear Case — Vijaya Diagnostic share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	1,140	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 987-1,140	High	FY27 in-line earnings, stable macro
Bear Case	Rs 650 zone	Low	FY27 guidance cut, prolonged FII selling

Vijaya Diagnostic Centre Share Price Reference Table

NSE Symbol	VIJAYA
CMP	Rs 820
52-Week High	Rs 1,120
52-Week Low	Rs 650
Market Cap	Rs 9,600 Cr
P/E	42x
Promoter	71.7%
FII	14.8%
Dividend FY26	Rs 5
Short-Term Target	Rs 987
12M Target	Rs 987-1,140
Upside	20-39%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Vijaya Diagnostic share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 984	FY27 earnings recovery and Diagnostics sector leadership
YES Securities	Buy	Rs 1,000	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 942	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Vijaya Diagnostic Centre.

How to Invest in Vijaya Diagnostic Centre — 5 Steps

Step 1: Research on the Univest Screener

Search VIJAYA on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Vijaya Diagnostic share price target 2026.

Step 2: Identify Entry Level

Vijaya Diagnostic Centre at Rs 820 has key support near Rs 650. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Vijaya Diagnostic share price target 2026 recovery is Rs 987.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 1,140 — the bull case for the Vijaya Diagnostic share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Vijaya Diagnostic share price target 2026.

Conclusion — Vijaya Diagnostic share price target 2026

Vijaya Diagnostic Centre (VIJAYA) at Rs 820 offers 20-39% potential upside to the 12-month Vijaya Diagnostic share price target 2026 consensus of Rs 987-1,140. The bull case to 1,140 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 650 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Vijaya Diagnostic Centre at current levels presents a monitored entry opportunity. For more Vijaya Diagnostic share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Vijaya Diagnostic share price target 2026

Q: What is Vijaya Diagnostic Centre share price target for 2026?

The 12-month Vijaya Diagnostic share price target 2026 analyst consensus is Rs 987-1,140 — implying 20-39% upside from CMP Rs 820. Bull case: 1,140. Bear case: Rs 650 zone. Track the live Vijaya Diagnostic share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Vijaya Diagnostic Centre a good buy at Rs 820?

This article does not constitute investment advice. At Rs 820, Vijaya Diagnostic Centre offers 20-39% upside to the Vijaya Diagnostic share price target 2026 consensus of Rs 987-1,140. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Vijaya Diagnostic Centre 52-week high and low?

Vijaya Diagnostic Centre’s 52-week high is Rs 1,120 and 52-week low is Rs 650. At the current CMP of Rs 820, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Vijaya Diagnostic share price target 2026 thesis.

Q: What sector is Vijaya Diagnostic Centre (VIJAYA) in?

Vijaya Diagnostic Centre operates in the Diagnostics / South India / Pathology / Radiology sector. India’s Diagnostics sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Vijaya Diagnostic share price target 2026 bull case.

Q: What are the main risks for the Vijaya Diagnostic share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at 42x requiring consistent execution, competition in Diagnostics, input cost volatility, and FII selling pressure (14.8% holding). Monitor quarterly earnings closely.

Q: What is Vijaya Diagnostic Centre’s market cap?

Vijaya Diagnostic Centre has a market cap of Rs 9,600 Cr as of April 2026. At the Vijaya Diagnostic share price target 2026 of Rs 987-1,140, the implied market cap would reflect 20-39% appreciation on the current base.

Q: What is Vijaya Diagnostic Centre dividend for FY26?

Vijaya Diagnostic Centre’s FY26 dividend is Rs 5. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Vijaya Diagnostic share price target 2026 capital appreciation potential.

Q: How to buy Vijaya Diagnostic Centre shares?

Buy Vijaya Diagnostic Centre (VIJAYA) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 650 support zone, and download the Univest App for SEBI-registered research on the Vijaya Diagnostic share price target 2026.